IONS News and Press, Ionis Pharmaceuticals Inc. From 01/19/26

2026-01-19 07:35:54 ET Cathie Wood’s ARK Invest ( ARKK ) deepened investment in AI chipmakers, gene-editing companies, and autonomous-driving developers while continuing to trim positions in Tesla ( TSLA ) and several mature tech companies and life...

2026-01-13 14:16:05 ET Ionis Pharmaceuticals, Inc. (IONS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 11:15 AM EST... Read the full article on Seeking Alpha For further details see: Ionis Pharmaceuticals, Inc. (IONS) Presents at 44th Annual J.P. Morgan Hea...

2026-01-13 06:42:00 ET A strong December capped a year of resilience for moat strategies, as quality stock selection and renewed exposure to mega-caps position them for 2026. ... Read the full article on Seeking Alpha For further details see: Stage Set For Moat Stock...

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA 1 Biogen is dedicated to partnering with the SMA community to advance care through scientific inn...

2026-01-12 07:30:18 ET More on Ark Invest ARKW: Fourth Quarter Retreat May Preview A Volatile 2026 ARKK: Heads You Don't Win, Tails You Lose QQQ Vs. ARKK: The Critical Role Of Equity Duration In Growth Investing Trump's tilt towards crypto remains strategic f...

– TRYNGOLZA® (olezarsen) outperforms expectations, achieved 2025 preliminary U.S. net product sales of $105M* as first FDA-approved treatment for FCS; sNDA for sHTG submitted for review – – Increasing annual TRYNGOLZA peak net sales guidance to >$2B for sHTG...

– Primary endpoint met in both trials – – Bepirovirsen demonstrated a statistically significant and clinically meaningful functional cure rate – – Chronic hepatitis B (CHB) accounts for ~56% of liver cancer cases and affects more than 250...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 44 th Annual J.P. Morgan Healthcare Conference at 8:15 a.m. PT on Tuesday, January 13, 2026. A live webcast of the presentation can be acc...

2026-01-05 07:20:16 ET More on ARK Invest ARKW: Fourth Quarter Retreat May Preview A Volatile 2026 ARKK: Heads You Don't Win, Tails You Lose QQQ Vs. ARKK: The Critical Role Of Equity Duration In Growth Investing From record highs to record outflows: Bitcoin E...

2025-12-30 22:11:33 ET This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne’s 13F portfolio on a quarterly basis. It is based on Tweedy Browne’s regulatory 13F Form filed on 11/20/2025. Please visit our Tracking Twee...